Zahra Ghasemi: The Role of Recovered and Source Plasma in Plasma Fractionation
Zahra Ghasemi, Pharmacoeconomist, Member of Health Technology Assessment international and Cochrane, shared a post on LinkedIn:
“It’s International Plasma Awareness Week, and it’s the perfect time to learn something new about plasma: the different ways it’s collected and how it becomes life-saving medicine.
Every Plasma Awareness Week, we say ‘Donate Plasma’, but which plasma?
Plasma reaches fractionation facilities in two ways: recovered and source.
Both can become immunoglobulins, albumin, and clotting factors, but each comes with its own challenges.
That’s why every health system eventually asks:
How much should we rely on each one?
How do we make sure recovered plasma isn’t wasted?
How do we scale up source plasma without compromising donor safety or quality?
So this Plasma Awareness Week, instead of only repeating the slogan, it’s worth learning how these decisions are actually made.
A good place to start is a two-day online workshop running today and tomorrow, hosted by the Iranian Blood Transfusion Organization and the High Institute for Research and Education in Transfusion Medicine, a WHO Collaborating Centre:
‘Optimal Collection and Fractionation of Recovered and Source Plasma.’
October 5–6, 2026 | 07:30–11:00 GMT (11:00–14:30 Tehran time)
Meeting ID: 976 3713 9064 | Passcode: CMS@OCF5
Some of the esteemed speakers include Dr. Ahmad Gharehbaghian, Prof. Albert Farrugia, Dr. Leni von Bonsdorff, Dr. Sedigheh Amini, Dr Mohammad Hessam Rafiee, Dr. Mahtab Maghsudlu, and experts from across Asia, the Middle East, and Europe.”
Other posts featuring Zahra Ghasemi on Hemostasis Today.
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?
-
Oct 7, 2026, 14:34Pre-Registration Ends for Our Webinar on Pregnancy and Thrombotic Risk – World Thrombosis Day
-
Oct 7, 2026, 14:19Maha Othman: Celebrating the Opening of The Current at St. Lawrence College
-
Oct 7, 2026, 14:09Ney Carter Borges: How ApoB and Lp(a) Shape Coronary Plaque Risk
-
Oct 7, 2026, 14:01Ronnie Hutcheon: The Risks of Incorrect Apixaban Dosing
-
Oct 7, 2026, 13:49A Plasma Proteomic Signature of Antiphospholipid Syndrome – JTH
-
Oct 7, 2026, 13:38Mary Panagrosso: Biology-Guided PRP for Musculoskeletal Disorders
-
Oct 7, 2026, 13:31Sihem Kebaili: Two Recent RPTH Publications Highlighting Rare Coagulation and Immune Thrombocytopenia Cases
-
Oct 7, 2026, 13:23Nisheeth Patel: The Clinical Balance Between Clot Prevention and Bleeding